| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |